S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
NASDAQ:FOLD

Amicus Therapeutics - FOLD News Headlines

$12.32
+0.26 (+2.16%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$12.08
$12.46
50-Day Range
$7.88
$12.73
52-Week Range
$5.91
$12.76
Volume
1.92 million shs
Average Volume
3.32 million shs
Market Capitalization
$3.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.25
Get Amicus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FOLD and its competitors with MarketBeat's FREE daily newsletter.

FOLD Media Mentions By Week

FOLD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FOLD
News Sentiment

1.27

0.63

Average
Medical
News Sentiment

FOLD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FOLD Articles
This Week

7

2

FOLD Articles
Average Week



SourceHeadline
seekingalpha.com logoAmicus Therapeutics: AT-GAA Approval Delayed, I Will Continue Holding
seekingalpha.com - August 10 at 12:11 PM
MarketBeat logoAmicus Therapeutics (NASDAQ:FOLD) Trading 10.6% Higher on Strong Earnings
americanbankingnews.com - August 7 at 1:44 AM
MarketBeat logoAmicus Therapeutics, Inc. (NASDAQ:FOLD) CEO Bradley L. Campbell Sells 5,470 Shares
americanbankingnews.com - August 6 at 6:08 AM
MarketBeat logoAmicus Therapeutics, Inc. (NASDAQ:FOLD) Chairman Sells $113,006.16 in Stock
americanbankingnews.com - August 6 at 5:32 AM
seekingalpha.com logoAmicus Therapeutics, Inc. (FOLD) CEO Bradley Campbell on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 7:50 AM
MarketBeat logoEllen Rosenberg Sells 11,123 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock
americanbankingnews.com - August 5 at 6:04 AM
finance.yahoo.com logoAmicus Therapeutics Announces Second Quarter 2022 Financial Results
finance.yahoo.com - August 4 at 10:42 AM
finance.yahoo.com logoAmicus Therapeutics (FOLD) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 4 at 10:42 AM
MarketBeat logoQ2 2022 EPS Estimates for Amicus Therapeutics, Inc. Increased by SVB Leerink (NASDAQ:FOLD)
americanbankingnews.com - July 30 at 1:48 AM
MarketBeat logoFY2023 EPS Estimates for Amicus Therapeutics, Inc. (NASDAQ:FOLD) Boosted by SVB Leerink
americanbankingnews.com - July 29 at 3:26 AM
finance.yahoo.com logoAmicus Therapeutics to Announce Second Quarter 2022 Financial Results on August 4, 2022
finance.yahoo.com - July 26 at 10:57 AM
MarketBeat logoInsider Selling: Amicus Therapeutics, Inc. (NASDAQ:FOLD) CEO Sells $113,682.48 in Stock
americanbankingnews.com - July 22 at 4:52 AM
finance.yahoo.com logoAmicus Therapeutics, Inc. (NASDAQ:FOLD) Is Expected To Breakeven In The Near Future
finance.yahoo.com - July 19 at 8:29 AM
msn.com logoShort Volatility Alert: Amicus Therapeutics, Inc.
msn.com - June 22 at 6:33 PM
finance.yahoo.com logoWhy Is Amicus Therapeutics (FOLD) Up 25.1% Since Last Earnings Report?
finance.yahoo.com - June 8 at 4:29 PM
finance.yahoo.com logoAmicus Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
finance.yahoo.com - June 8 at 11:29 AM
finance.yahoo.com logoIs Amicus Therapeutics (NASDAQ:FOLD) Weighed On By Its Debt Load?
finance.yahoo.com - June 5 at 6:14 PM
finance.yahoo.com logoAmicus' (FOLD) Galafold Aids Growth, Overdependence a Woe
finance.yahoo.com - May 31 at 5:04 PM
nasdaq.com logoLitecoin vs. Amicus Therapeutics: Price Relationship Crosses Threshold
nasdaq.com - May 13 at 6:29 PM
finance.yahoo.com logoAmicus Therapeutics Receives Notification of PDUFA Date Extensions for AT-GAA
finance.yahoo.com - May 10 at 4:13 PM
seekingalpha.com logoAmicus Therapeutics, Inc.'s (FOLD) CEO John Crowley on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 6:08 PM
finance.yahoo.com logoCORRECTING AND REPLACING -- Amicus Therapeutics Announces First Quarter 2022 Financial Results
finance.yahoo.com - May 9 at 1:06 PM
seekingalpha.com logoAmicus Therapeutics GAAP EPS of -$0.30 misses by $0.04, revenue of $78.7M beats by $1.56M; updates FY22 guidance
seekingalpha.com - May 9 at 8:06 AM
finance.yahoo.com logoAmicus Therapeutics Announces First Quarter 2022 Financial Results
finance.yahoo.com - May 9 at 8:06 AM
nasdaq.com logoWhy Amicus (FOLD) Might Surprise This Earnings Season
nasdaq.com - May 6 at 8:28 PM
finance.yahoo.com logoInsiders who bought stock earlier this year lose -US$61k as Amicus Therapeutics, Inc. (NASDAQ:FOLD) drops to US$1.9b
finance.yahoo.com - May 6 at 10:27 AM
finance.yahoo.com logoBears are Losing Control Over Amicus Therapeutics (FOLD), Here's Why It's a 'Buy' Now
finance.yahoo.com - May 5 at 1:44 PM
finance.yahoo.com logoAmicus Therapeutics to Present at the Bank of America 2022 Healthcare Conference
finance.yahoo.com - May 4 at 10:23 AM
finance.yahoo.com logo10 Best Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
finance.yahoo.com - May 3 at 2:02 PM
seekingalpha.com logoAmicus Therapeutics: An Inflection Point In Growth
seekingalpha.com - April 27 at 7:45 PM
finance.yahoo.com logoAmicus Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022
finance.yahoo.com - April 26 at 9:08 AM
nasdaq.com logoInteresting FOLD Put And Call Options For June 17th
nasdaq.com - April 20 at 1:49 PM
seekingalpha.com logoAmicus gets US patent related to Fabry disease drug Galafold
seekingalpha.com - April 19 at 1:11 PM
finance.yahoo.com logoFurther weakness as Amicus Therapeutics (NASDAQ:FOLD) drops 7.2% this week, taking three-year losses to 31%
finance.yahoo.com - March 28 at 11:05 PM
finance.yahoo.com logoAmicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease
finance.yahoo.com - March 16 at 5:22 PM
tmcnet.com logoAmicus Therapeutics Announces Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Disease at the 2022 MDA Clinical & Scientific Conference
tmcnet.com - March 16 at 7:19 AM
finance.yahoo.com logoAmicus Therapeutics Announces Presentation and Posters at the 2022 MDA Clinical & Scientific Conference
finance.yahoo.com - March 10 at 8:24 AM
finance.yahoo.com logoAmicus Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
finance.yahoo.com - March 1 at 1:01 PM
bizjournals.com logoAmicus scraps plans for $600M gene therapy spinoff due to 'challenging environment'
bizjournals.com - February 25 at 8:34 AM
thestreet.com logoARYD/Amicus break up, BigBear.ai looks ready for a squeeze, Rigetti/Supernova at the wire
thestreet.com - February 24 at 8:39 PM
seekingalpha.com logoAmicus, SPAC ARYA mutually terminate business combination for Caritas Therapeutics
seekingalpha.com - February 24 at 10:36 AM
finance.yahoo.com logoARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions
finance.yahoo.com - February 24 at 10:36 AM
finance.yahoo.com logoAmicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
finance.yahoo.com - February 24 at 10:36 AM
seekingalpha.com logoAmicus Therapeutics FY 2021 Earnings Preview
seekingalpha.com - February 23 at 12:28 PM
benzinga.com logoAmicus Therapeutics Earnings Preview
benzinga.com - February 23 at 12:28 PM
finance.yahoo.com logoAmicus Therapeutics (FOLD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
finance.yahoo.com - February 17 at 6:49 PM
finance.yahoo.com logoWhen Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
finance.yahoo.com - February 9 at 9:24 AM
markets.businessinsider.com logoCongruence Therapeutics Inc. Announces US$50 million Series A Financing to Advance Platform Targeting Diseases of Protein Misfolding
markets.businessinsider.com - February 8 at 1:23 PM
finance.yahoo.com logoWere Hedge Funds Right About Amicus Therapeutics, Inc. (FOLD)?
finance.yahoo.com - February 7 at 4:39 PM
finance.yahoo.com logoAmicus Therapeutics Announces Presentations and Posters at the 18th Annual WORLDSymposium™ 2022
finance.yahoo.com - February 7 at 11:38 AM
Get Amicus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FOLD and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:FOLD) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.